Software Healthcare Sector

Nuvectis Pharma

Market Cap: US$626.5m

A clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology.

MiMedx Group

Market Cap: US$612.2m

Develops and distributes placental tissue allografts for various sectors of healthcare.

Verastem

Market Cap: US$604.1m

A development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States.

Delcath Systems

Market Cap: US$602.4m

An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

Cerus

Market Cap: US$600.5m

Operates as a biomedical products company.

Eikon Therapeutics

Market Cap: US$598.5m

Operates as a clinical biopharmaceutical company in the United States.

American Oncology Network

Market Cap: US$592.9m

Through its subsidiaries, provides oncology management services in the United States.

Integral Diagnostics

Market Cap: AU$834.4m

A healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.

Arvinas

Market Cap: US$589.1m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Craneware

Market Cap: UK£435.0m

Develops, licenses, and supports computer software for the healthcare industry in the United States.

CorMedix

Market Cap: US$587.7m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Sagimet Biosciences

Market Cap: US$576.8m

A clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States.

Contineum Therapeutics

Market Cap: US$575.6m

A clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States.

Autolus Therapeutics

Market Cap: US$572.2m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally.

Altimmune

Market Cap: US$571.9m

A late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases.

Prelude Therapeutics

Market Cap: US$571.6m

A clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.

ARS Pharmaceuticals

Market Cap: US$561.9m

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.

Artiva Biotherapeutics

Market Cap: US$559.8m

A clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.

Artrya

Market Cap: AU$783.9m

A medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia.

Ovid Therapeutics

Market Cap: US$552.7m

A biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States.

Prime Medicine

Market Cap: US$549.7m

A biotechnology company, engages in delivering genetic medicines to address the spectrum of diseases by deploying gene editing technology in the United States.

Tactile Systems Technology

Market Cap: US$548.2m

A medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.

Veradigm

Market Cap: US$545.0m

A healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally.

MapLight Therapeutics

Market Cap: US$537.1m

Operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders.

Zura Bio

Market Cap: US$533.8m

A clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States.

Aquestive Therapeutics

Market Cap: US$533.4m

Operates as a pharmaceutical company in the United States and internationally.

Vireo Growth

Market Cap: CA$739.6m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah.

Evommune

Market Cap: US$531.7m

Operates as a clinical-stage biotechnology company in the United States.

Adlai Nortye

Market Cap: US$530.0m

A clinical-stage company, together with its subsidiaries, engages in the research and develops pharmaceutical products.

Evolus

Market Cap: US$529.7m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

Evolent Health

Market Cap: US$529.1m

Through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.

Strata Critical Medical

Market Cap: US$522.0m

Provides time-critical logistics and medical services to the healthcare industry in the United States.

Imricor Medical Systems

Market Cap: AU$731.5m

A medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East.

Relmada Therapeutics

Market Cap: US$512.0m

Operates as a clinical-stage biotechnology company in the United States.

Fulgent Genetics

Market Cap: US$510.7m

Provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.

C4 Therapeutics

Market Cap: US$501.9m

A clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins.